Internal Audit Keeps Takeda’s Deeply Rooted Culture in Focus When Assessing Risk
Subscriber Content

Takeda is the largest pharmaceutical company in Japan and Asia, and one of the leading companies in the industry world-wide. Katsuaki Kaneko, Senior Vice President, Head of Group Internal Audit says, “Fortunately, Takeda’s senior management team has given me a mandate — and the funding — to change my function’s culture and audit practice so that we can provide strategic advice and align our goals with the company’s strategy and goals. We are in a unique position that enables us to help management deliver messages about culture and risk to people throughout the global organization.” In the future, Kaneko says he would like his team to conduct stand-alone thematic audits of Takeda’s culture.